Medicine
Casgevy 13000000/mL injectable suspension
Casgevy 13000000/mL injectable suspension is a prescription medicine containing Exagamglogene autotemcel for intravenous use, marketed by Vertex Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not re-freeze CASGEVY after thawing. Store the vial(s) in the vapor phase…
Key facts
- Active ingredient (INN)
- Exagamglogene autotemcel
- Brand
- Casgevy
- Strength
- 13000000/mL
- Dosage form
- Injectable suspension
- Route
- Intravenous
- Packs
- 9 vials
- Marketing authorisation holder
- Vertex Pharmaceuticals
- Manufacturer
- Vertex Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not re-freeze CASGEVY after thawing. Store the vial(s) in the vapor phase of liquid nitrogen at ≤ -135 °C (≤ -211 °F) until ready for thaw and administration.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B06AX05 Exagamglogene autotemcel
- HS code (indicative)
- 3002.51Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 December 2023
- Identifiers
- RxCUI 2671671, 2671677DailyMed set ID 7c3e12ad-e2fe-4d3f-a630-ea7364d9e846NDC 51167-290Application BLA125787
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 9 vial in 1 carton / 20 mL in 1 vial | 51167-290-09 | Vertex Pharmaceuticals | 8 December 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Exagamglogene autotemcel is a prescription medicine. It is available as injectable suspension for intravenous use. MedsAcross supplies Exagamglogene autotemcel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Exagamglogene autotemcelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CASGEVY prescribing information (Vertex Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Casgevy: European public assessment report (EPAR) · European Medicines Agency
Need Casgevy 13000000/mL injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.